Applied Therapeutics (APLT) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$11.9 million.
- Applied Therapeutics' Enterprise Value rose 8792.21% to -$11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.9 million, marking a year-over-year increase of 8792.21%. This contributed to the annual value of -$79.4 million for FY2024, which is 5912.06% down from last year.
- Applied Therapeutics' Enterprise Value amounted to -$11.9 million in Q3 2025, which was up 8792.21% from -$30.4 million recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' Enterprise Value ranged from a high of -$11.9 million in Q3 2025 and a low of -$146.5 million during Q1 2024
- Its 3-year average for Enterprise Value is -$62.4 million, with a median of -$49.9 million in 2023.
- In the last 5 years, Applied Therapeutics' Enterprise Value plummeted by 53926.34% in 2024 and then surged by 8792.21% in 2025.
- Over the past 3 years, Applied Therapeutics' Enterprise Value (Quarter) stood at -$49.9 million in 2023, then plummeted by 59.12% to -$79.4 million in 2024, then skyrocketed by 84.96% to -$11.9 million in 2025.
- Its last three reported values are -$11.9 million in Q3 2025, -$30.4 million for Q2 2025, and -$50.8 million during Q1 2025.